ConAlliance advises sellers, buyers, and insolvency administrators on transactions involving distressed companies or segments thereof.
Distressed Mergers & Acquisitions involve the sale and purchase of entire corporate groups, individual entities, specific assets (“distressed assets”), and/or non-performing loans. During crisis-driven transactions, not only are core transaction skills in restructuring, turnaround planning, execution experience, and negotiation strength essential. Equally critical is direct and personal access to an investor network specialized in the healthcare sector, allowing for time efficiencies and expanded options.
While distressed M&A processes cover typical M&A functions, they come with unique challenges: financial strain, intense time pressures, elevated risk levels including management liability, and urgent, high-stakes decisions. These processes require timely and accurate interpretation of insolvency regulations, management of complex stakeholder relationships, and navigation of restricted operational flexibility imposed by external parties (such as banks). Frequently incomplete and opaque information, coupled with a heightened need for in-depth analysis, makes managing distressed M&A transactions a uniquely demanding task.
ConAlliance supports healthcare companies in proactively avoiding crises or resolving them through targeted distressed healthcare M&A transactions. Our specialists, focused exclusively on the healthcare sector, bring extensive transaction experience and crisis resilience. With the necessary industry expertise and market transparency, we facilitate swift and stakeholder-aligned transactions for distressed healthcare companies, prioritizing the preservation of remaining enterprise value.
Our crisis managers at ConAlliance establish immediate, discreet, and anonymized initial contact with suitable investors. These investors are strategically aligned, highly motivated, and possess the financial capacity and creditworthiness to complete transactions even under difficult circumstances. Our network enables us to provide our healthcare clients with optimal transaction execution in a necessarily shortened timeframe when restructuring funds or refinancing options are unavailable, making a company sale the last viable option to preserve value and secure an acceptable sale price.
Our M&A experts offer experience in distressed situations and as interim managers. They have deep industry knowledge and a proven track record in healthcare segments such as medical technology, medical devices, long-term care, pharmaceuticals, biotechnology, and medical laboratories and diagnostics. With a well-established international network and partner offices in key regions across Europe, the U.S., and Asia, and a structured approach to time-sensitive transactions, ConAlliance is well-positioned to support healthcare companies facing crises.
In times of crisis, selling all or part of a distressed company is often not only the best but also the only viable option for shareholders to recover value. Waiting too long can lead directly to insolvency, and proactive steps are essential to prevent this outcome.
Engaging ConAlliance restructuring experts early opens up a broader range of strategic options, maximizing the potential for a successful transaction. Despite the urgency and complexities involved, it is critical to avoid further strain on core assets such as the company’s reputation, brand image, and essential relationships with employees, clients, suppliers, and financial institutions. There is a clear need for experienced professionals to drive a swift, effective transaction process.
Shareholders and management in crisis situations face a complex web of priorities, including:
At ConAlliance, we incorporate the priorities of all stakeholders—including banks, management, employees, suppliers, and, when applicable, key customers—into the distressed transaction strategy. Navigating these transactions requires meticulous planning and execution. Our M&A specialists begin by addressing core strategic questions:
Furthermore, in close coordination with our clients, we define:
ConAlliance’s expertise ensures that every aspect of the divestment process is handled with precision, protecting and enhancing shareholder value under challenging conditions. Our approach allows clients to navigate even the most complex crises with strategic clarity and confidence.
From an investor’s standpoint, it is essential to thoroughly assess whether pursuing an acquisition in a distressed or insolvent situation aligns with realistic success prospects. Key questions include: What are the associated risks, and can they be effectively mitigated or eliminated? What is the financing requirement, and does the acquisition make strategic sense?
ConAlliance provides the transparency necessary for investors to evaluate the insolvency risks alongside the unique objectives of different stakeholder groups, ensuring a well-informed decision process.
Our distressed M&A specialists meticulously evaluate the fundamental drivers behind the acquisition decision, weighing the potential benefits and drawbacks with precision.
If the acquisition proceeds, ConAlliance structures the deal to achieve optimal outcomes for the buyer. We customize the approach based on the transaction type, employing either an asset deal or a share deal as appropriate.
In an asset deal, ConAlliance focuses on cherry-picking valuable assets, ensuring buyers acquire only the most beneficial parts of the business while sidestepping unwanted liabilities. Key steps include:
Unlike asset deals, a share deal involves coordinating with both the insolvency administrator and existing shareholders. This comprehensive approach ensures alignment and continuity of ownership, making the transaction more complex but potentially rewarding. ConAlliance carefully evaluates target suitability through:
ConAlliance’s expertise enables clients to navigate the intricacies of distressed acquisitions with strategic foresight and control. Our team ensures that every decision is thoroughly vetted, aligning each transaction with the client’s objectives and mitigating risks in highly complex crisis scenarios.
Once formal insolvency proceedings begin, an interim insolvency administrator is appointed and later confirmed by the creditors’ assembly. At this point, the administrator assumes not only managerial and dispositional control over the distressed company but also the role of employer, taking on significant responsibility.
ConAlliance’s extensive experience in distressed healthcare M&A, particularly in insolvency scenarios, aligns closely with the time-sensitive goals of insolvency administrators. Our support includes:
ConAlliance offers a specialized advantage to administrators by relieving them of intensive strategic analysis and planning requirements, ensuring a thorough review of both the horizontal and vertical value chains to maximize the pool and quality of potential buyers. Specifically, our support comprises:
By partnering with ConAlliance, insolvency administrators not only improve their likelihood of securing an optimal buyer within tight deadlines but also reduce the risk of wasted resources on unsuitable prospects.
Errors in identifying potential buyers can have serious repercussions, such as:
Working with ConAlliance’s M&A healthcare specialists offers administrators:
ConAlliance’s involvement boosts efficiency and outcomes across several critical dimensions:
ConAlliance enables insolvency administrators to execute their mandates with precision and achieve optimal outcomes under challenging conditions, positioning them for success in even the most complex distressed scenarios.
M&A in Distressed Situations: Contact Us to Learn More About Our Approach.